These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37255473)

  • 1. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
    Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
    Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
    Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.
    Shang Y; Chen S; Shi W; Nie W; Jing W; Huo F; Xue Y; Dong L; Jiang G; Huang H; Chu N
    J Glob Antimicrob Resist; 2023 Jun; 33():294-300. PubMed ID: 37142094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
    Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
    Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
    Andries K; Villellas C; Coeck N; Thys K; Gevers T; Vranckx L; Lounis N; de Jong BC; Koul A
    PLoS One; 2014; 9(7):e102135. PubMed ID: 25010492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.
    Almeida D; Ioerger T; Tyagi S; Li SY; Mdluli K; Andries K; Grosset J; Sacchettini J; Nuermberger E
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4590-9. PubMed ID: 27185800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
    Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
    BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
    Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
    Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant
    Xu J; Converse PJ; Upton AM; Mdluli K; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
    J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Canonical and Noncanonical Genomic Variants following
    Ismail N; Dippenaar A; Warren RM; Peters RPH; Omar SV
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0136822. PubMed ID: 36892309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-MIC levels of bedaquiline and clofazimine can select
    Villellas C; Stevenaert F; Remmerie B; Andries K
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0127523. PubMed ID: 38470194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
    Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
    Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant
    Almeida D; Converse PJ; Li SY; Upton AM; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0141221. PubMed ID: 34570644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofazimine Exposure
    Ismail N; Peters RPH; Ismail NA; Omar SV
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.
    Sonnenkalb L; Carter JJ; Spitaleri A; Iqbal Z; Hunt M; Malone KM; Utpatel C; Cirillo DM; Rodrigues C; Nilgiriwala KS; Fowler PW; Merker M; Niemann S;
    Lancet Microbe; 2023 May; 4(5):e358-e368. PubMed ID: 37003285
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Degiacomi G; Sammartino JC; Sinigiani V; Marra P; Urbani A; Pasca MR
    Front Microbiol; 2020; 11():559469. PubMed ID: 33042066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
    Brown TS; Tang L; Omar SV; Joseph L; Meintjes G; Maartens G; Wasserman S; Shah NS; Farhat MR; Gandhi NR; Ismail N; Brust JCM; Mathema B
    Clin Infect Dis; 2024 Feb; 78(2):269-276. PubMed ID: 37874928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in
    Singh BK; Soneja M; Sharma R; Chaubey J; Kodan P; Jorwal P; Nischal N; Chandra S; Ramachandran R; Wig N
    Int J Mycobacteriol; 2020; 9(2):212-215. PubMed ID: 32474547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
    Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.